Integrated report 2020

 Menu

Currently viewing: International footprint / Next: Overview of our international portfolio

International footprint

  • Alliance Medical is Europe’s leading provider of diagnostic imaging services and integrated molecular imaging services with an expanding network of radiopharmacies.
  • Life Molecular Imaging is a fully integrated research and development pharma company dedicated to developing and commercialising innovative molecular imaging agents for use in PET-CT diagnostics.
  • Scanmed operates in 42 locations across Poland and offers comprehensive medical services in acute facilities, cardiac centres, monoclinics and outpatient facilities.

 

  Alliance Medical 2020 2019  
  Revenue R6.3 billion R5.6 billion  
  EBITDA pre-IFRS 16 R1.2 billion R1.3  billion  
  Number of locations served 233 220  
  Number of permanent employees 2 160 2 040  
  Number of machines 265 244  
  Number of cyclotron locations 10 9  
  LMI 2020 2019   
  Revenue R319 million R268 million   
  EBITDA pre-IFRS 161 R1 million (R12 million)  
  1 Excludes non-trading foreign exchange loss of R8 million (2019: R30 million profit)
  Scanmed 2020 2019  
  Revenue R1 535 million R1 349 million  
  EBITDA pre-IFRS 16 R140 million R97 million  
  Medical facilities 42 41  
  Cardiac units 13 12  
  Registered beds 582 579  
Back to top